Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies

Modern Rheumatology

Volumn 22, Issue 4, 2012, Pages 625-629

  Sato, Shinji ^a   Kuwana, Masataka ^b   Fujita, Takashi ^c   Suzuki, Yasuo ^a  

^a TOKAI UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Anti CADM 140 autoantibodies; Anti MDA5 autoantibodies; Clinically amyopathic dermatomyositis (CADM); Dermatomyositis (DM); Rapidly progressive interstitial lung disease (RP ILD)

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOSPORIN A; MDA5 AUTOANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AMYOPATHIC DERMATOMYOSITIS; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; DISEASE COURSE; DRUG DOSE INCREASE; ELECTROMYOGRAPHY; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LABORATORY TEST; LOW DRUG DOSE; LUNG FUNCTION TEST; PRIORITY JOURNAL;

AUTOANTIBODIES; CYCLOSPORINE; DERMATOLOGIC AGENTS; DERMATOMYOSITIS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; PEPTIDES; PREDNISOLONE; TREATMENT OUTCOME;

EID: 84865356852     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0558-9     Document Type: Article

References (21)

1. Pearson CM. Polymyositis and dermatomyositis. In: McCarty DJ, editor. Arthritis and allied condition. 9th ed. Philadelphia: Lea and Febiger; 1979. p. 742.
2. Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626-36.
3. Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med. 1986;80: 329-32. (Pubitemid 16140792)
4. Ito M, Kaise S, Suzuki S, Kazuta Y, Sato Y, Miyata M, et al. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol. 1999;18:462-7. (Pubitemid 30014165)
5. Nagatomo Y, Okayama A, Murai K, Sasaki T, Kuroki M, Tanaka G, et al. Successful treatment using high-dose intravenous immunoglobulin in a patient with rapidly progressive interstitial pneumonia associated with dermatomyositis. Mod Rheumatol. 2000;10:165-8.
6. Chow SK, Yeap SS. Amyopathic dermatomyositis and pulmonary fibrosis. Clin Rheumatol. 2000;19:484-5. (Pubitemid 32039672)
7. Miyake S, Ohtani Y, Sawada M, Inase N, Miyazaki Y, Takano S, et al. Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis. Sarcoidosis Vasc Diffuse Lung Dis. 2002;19:128-33. (Pubitemid 34685912)
8. Lee CS, Chen TL, Tzen CY, Lin FJ, Peng MJ, Wu CL, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol. 2002;21:391-6.
9. High WA, Cohen JB, Murphy BA, Costner MI. Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis. J Am Acad Dermatol. 2003;49:295-8. (Pubitemid 36951282)
10. Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford). 2005;44:1282-6. (Pubitemid 41487962)
11. Neuhaus IM, Connolly MK. An unusual presentation of amyopathic dermatomyositis associated with fatal interstitial lung disease. Arch Dermatol. 2006;142:113-4. (Pubitemid 43107377)
12. Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T, et al. Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J. 2006;28:1005-12. (Pubitemid 46331972)
13. Ye S, Chen XX, Lu XY, Wu MF, Deng Y, Huang WQ, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol. 2007;26:1647-54.
14. Miyazaki E, Ando M, Muramatsu T, Fukami T, Matsuno O, Nureki S, et al. Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis. Clin Rheumatol. 2007;26:436-9. (Pubitemid 46486980)
15. Ideura G, Hanaoka M, Koizumi T, Fujimoto K, Shimojima Y, Ishii W, et al. Interstitial lung disease associated with amyopathic dermatomyositis: review of 18 cases. Respir Med. 2007;101: 1406-11. (Pubitemid 46832235)
16. Kakugawa T, Mukae H, Saito M, Ishii K, Ishimoto H, Sakamoto N, et al. Rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis successfully treated with polymyxin B-immobilized fiber column hemoperfusion. Intern Med. 2008;47:785-90. (Pubitemid 351936231)
17. Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52:1571-6. (Pubitemid 40663949)
18. Gono T, Kawaguchi Y, Ozeki E, Ota Y, Satoh T, Kuwana M, et al. Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol. 2010 Nov 5. Epub ahead of print.
19. Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Kuwana M. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009;60:2193-200.
20. Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, et al. HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med. 2011;105:1380-7.
21. Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 2011;65:25-34.